THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. (TSOI)
Clinical trial NCT07227103 updates: 1. start date: 2026-03-01 → 2026-09-01 2. completion date: 2027-03-31 → 2028-03-31 3. primary completion date: 2026-12-31 → 2027-12-31 4. enrollment: 120 → 400 participants 5. collaborators added: Zeta Surgical, Inc., HOPE Therapeutics, Inc., neurocare group AG 6. collaborators removed: AMPA Health, Inc.
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical